期刊文献+

连续性干预在阵发性房颤射频消融术后患者中的应用价值 被引量:3

下载PDF
导出
摘要 目的探究连续干预在阵发性房颤患者射频消融术后的应用效果。方法选取2016年12月~2018年6月我院收治的阵发性房颤患者74例,均行射频消融术治疗,依据入院时间顺序分为两组各37例。对照组予以常规干预,于此基础上,观察组予以连续干预。统计对比两组用药依从性、干预满意度,观察比较两组干预前后负性情绪评分:抑郁(SDS)、焦虑(SAS),观察比较干预前后生活质量评分。结果干预后,观察组SAS、SDS评分均低于对照组,差异均有统计学意义(P<0.05);观察组用药依从性高于对照组,差异有统计学意义(P<0.05);观察组干预后生活质量评分高于对照组,差异有统计学意义(P<0.05);观察组干预满意度高于对照组,差异有统计学意义(P<0.05)。结论对行射频消融术的阵发性房颤患者予以连续干预,可显著改善患者负性情绪,提高用药依从性及生活质量,且患者对干预满意度较高。
作者 阮静
出处 《现代诊断与治疗》 CAS 2020年第15期2514-2516,共3页 Modern Diagnosis and Treatment
  • 相关文献

参考文献9

二级参考文献67

  • 1张克宁,黄申申,李捷,汤玉凤.胺碘酮治疗高血压病伴阵发性房颤的疗效观察[J].中国药师,2005,8(12):1026-1027. 被引量:1
  • 2Zung WW. A self-rating depression scale. Arch Gen Psychiatry[ J]. 1965,12:63.
  • 3Zung WW. A rating instrument for anxiety disorders. Psychosomat-ics[J]. 1971,12:371.
  • 4Fang Y,Yuan C,Xu Y, et al. Comparisons of the efficacy and tol-erability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression : a double-blind, randomized pilot study in a Chinese population [ J ]. J Clin Psychopharmacol, 2010,30-.357.
  • 5McHomey CA, Jr Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36) : II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care[J], 1993,31:247.
  • 6Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey : translation ,cultural adaptation,validation,and normalisation[ J]. J Epidemiol Community Health, 2003,57 :259.
  • 7Thrall G, Lip GY, Carroll D, Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation [ J]. Chest,2007, 132:1 259.
  • 8Pappone C, Rosanio S, Augello G,et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation : outcomes from a controlled nonrandomized long-term study[ J]. J Am Coll Cardiol, 2003 ,42 : 185.
  • 9Fogari R,Mugellini A,Zoppi A,et al.Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation[J].J Cardiovasc Pharmacol Ther,2012,17(1):34-43.
  • 10Chiang CE,Goethals M,O'Neill JO,et al.Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey:Insights from Realise AF[J].Europace,2013,15(12):1733-1740.

共引文献95

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部